When Alexander Hamilton wrote his classic analysis of the presidency in The Federalist Papers (No. 70), he minced no words: “Energy in the executive is a leading character in the definition of good government.” The executive branch has to act and act decisively. The legislative process is not designed for speed, nor is adjudication in the courts. The presidency is—and needs to be. As commander in chief, the president has to be ready to address whatever crisis the nation faces.
The alternative to an energetic executive, Hamilton explained, is a “feeble” executive. A feeble executive will act feebly. And “feeble execution is but another phrase for a bad execution: And a government ill executed, whatever it may be in theory, must be in practice a bad government.”
The designers of the Constitution could not, of course, know who would occupy the office in the future. What they could do was design the Constitution so as to give future presidents the ability to act decisively and energetically.
That is why, Hamilton explained, there is one president, not two and not a council. When multiple people have to agree on any particular action, there’s always the possibility for delay or even gridlock. Checks and balances are, indeed, important in the right context. But checks and balances on military strategy when the battle is underway can be fatal. So “[t]he executive power”—not some, but the entirety—is “vested” in the president by Article II of the Constitution.
As Hamilton explained, decisiveness and promptness “will generally characterise the proceedings of one man, in a much more eminent degree, than the proceedings of any greater number.” So having a single, unitary executive who has the final decision-making power is a key feature of the Constitution’s design for the presidency. President Harry Truman captured the point succinctly with the sign he placed on his desk: “The buck stops here.”
-- Lael Weinberger
The FDA has rejected its strongest safety warning for Covid mRNA vaccines despite acknowledging that children were killed by the products.
This news surfaced during a televised Bloomberg interview with FDA Commissioner Marty Makary, who said the agency has “no plans” to apply its strongest safety warning to Covid mRNA vaccines.
In that interview, Makary confirmed that the FDA’s own safety and epidemiology centre had formally recommended a boxed warning — a step reserved, under FDA rules, for drugs with “special problems, particularly ones that may lead to death or serious injury.”